Expression of CD24 in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance

Urology

Volumn 72, Issue 3, 2008, Pages 603-607

  Lee, Hyun Ju ^a   Kim, Dong Il ^b   Kwak, Cheol ^a   Ku, Ja Hyeon ^a   Moon, Kyung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD24; CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MEDICAL ONCOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UROLOGY;

EID: 50249095081     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.01.061     Document Type: Article

References (29)

1. Shuch B.M., Lam J.S., Belldegrun A.S., et al. Prognostic factors in renal cell carcinoma. Semin Oncol 33 (2006) 563-575
2. Pirruccello S.J., and LeBien T.W. The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. J Immunol 136 (1986) 3779-3784
3. Fischer G.F., Majdic O., Gadd S., et al. Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol 144 (1990) 638-641
4. Figarella-Branger D., Moreau H., Pellissier J.F., et al. CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle. Acta Neuropathol (Berl) 86 (1993) 275-284
5. Shirasawa T., Akashi T., Sakamoto K., et al. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues. Dev Dyn 198 (1993) 1-13
6. Poncet C., Frances V., Gristina R., et al. CD24, a glycosylphosphatidylinositol-anchored molecules is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors. Acta Neuropathol (Berl) 91 (1996) 400-408
7. Kristiansen G., Sammar M., and Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol 35 (2004) 255-262
8. Kristiansen G., Winzer K.J., Mayordomo E., et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 9 (2003) 4906-4913
9. Kristiansen G., Schluns K., Yongwei Y., et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. Br J Cancer 88 (2003) 231-236
10. Kristiansen G., Pilarsky C., Pervan J., et al. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer. Prostate 58 (2004) 183-192
11. Winkler A., Zigeuner R., Rehak P., et al. CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. Virchows Arch 450 (2007) 59-64
12. Droz D., Zachar D., Charbit L., et al. Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol 137 (1990) 895-905
13. Sobin L.H., Wittekind C., and International Union Against Cancer. TNM: Classification of Malignant Tumours (2002), Wiley-Liss, New York pp xxiii, 193-195
14. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655-663
15. Sammar M., Aigner S., Hubbe M., et al. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol 6 (1994) 1027-1036
16. Lim S.C. CD24 and human carcinoma: tumor biological aspects. Biomed Pharmacother 59 suppl 2 (2005) S351-S354
17. Karran L., Jones M., Morley G., et al. Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells. Int J Cancer 60 (1995) 562-566
18. Huang L.R., and Hsu H.C. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Cancer Res 55 (1995) 4717-4721
19. Fogel M., Friederichs J., Zeller Y., et al. CD24 is a marker for human breast carcinoma. Cancer Lett 143 (1999) 87-94
20. Jacob J., Bellach J., Grutzmann R., et al. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades. Pancreatology 4 (2004) 454-460
21. Zarn J.A., Jackson D.G., Bell M.V., et al. The small cell lung cancer antigen cluster-4 and the leukocyte antigen CD24 are allelic isoforms of the same gene (CD24) on chromosome band 6q21. Cytogenet Cell Genet 70 (1995) 119-125
22. Paraf F., Chauveau D., Chretien Y., et al. Renal lesions in von Hippel-Lindau disease: immunohistochemical expression of nephron differentiation molecules, adhesion molecules and apoptosis proteins. Histopathology 36 (2000) 457-465
23. Smith S.C., Oxford G., Wu Z., et al. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 66 (2006) 1917-1922
24. Surowiak P., Materna V., Kaplenko I., et al. Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue. Int J Gynecol Cancer 16 (2006) 515-521
25. Choi Y.L., Kim S.H., Shin Y.K., et al. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. Gynecol Oncol 97 (2005) 379-386
26. Weichert W., Denkert C., Burkhardt M., et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival. Clin Cancer Res 11 (2005) 6574-6581
27. Su M.C., Hsu C., Kao H.L., et al. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Cancer Lett 235 (2006) 34-39
28. Senner V., Sturm A., Baur I., et al. CD24 promotes invasion of glioma cells in vivo. J Neuropathol Exp Neurol 58 (1999) 795-802
29. Friederichs J., Zeller Y., Hafezi-Moghadam A., et al. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells. Cancer Res 60 (2000) 6714-6722